CluePoints opens U.S. office

Wednesday, May 3, 2017

CluePoints, a provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, will be expanding its operations in the U.S. with the opening of a new office in Wayne, Pennsylvania. The expansion marks a key milestone in CluePoints’ growth strategy that will see the company build its infrastructure to support its rapidly growing U.S. client base.

[Read More]

New data mapping software zeroes in on anomalies, trends

Monday, March 27, 2017

With thousands of data points collected in nearly every clinical trial, tech companies have been working to develop new ways to help teams sort out critical information. Recently, CluePoints announced the launch of Patient Profiles, a highly configurable platform that prioritizes atypical data, in an effort to help teams focus on at-risk study participants.

[Read More]

CluePoints adds Patient Profiles to RBM and Data Quality Oversight solution

Monday, March 13, 2017

CluePoints, a provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has introduced Patient Profiles to its rapidly expanding platform. The combination of Patient Profile reports, guided by CluePoints’ central statistical monitoring, offers a new way for clinical teams to prioritize the investigation of atypical patients in clinical trials.

[Read More]

CluePoints, Metrics Champion Consortium partner

Wednesday, November 9, 2016

CluePoints, a provider of centralized statistical monitoring (CSM) and risk-based monitoring (RBM) solutions for clinical trials, has partnered with the Metrics Champion Consortium (MCC), an association dedicated to the development of standardized performance metrics to improve clinical trials. Drawing on the company’s vast expertise in RBM, CluePoints will work with the consortium to help drive collaboration in the development of a standardized framework for Central Monitoring, including identification and definition of what is included, who should be involved, and how best to manage the process.  

[Read More]

CluePoints launches data quality oversight service for site inspection readiness

Wednesday, November 2, 2016

CluePoints, a provider of Risk-Based Monitoring (RBM) and Centralized Statistical Monitoring (CSM) solutions for clinical trials, has announced a new Data Quality Oversight service, RADAR, aimed at helping sponsors achieve a data-driven understanding of risks to an inspection-ready level. As regulators insist that sponsors adopt more comprehensive quality oversight methodologies, this new service looks to move away from antiquated processes to a more rigorous statistical approach to operational quality assurance including preparation for site inspections.

[Read More]